Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04932031Terminated

Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy

Role: lead

NCT03635606Completed

GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients

Role: lead

NCT05123859Completed

Patterns of Natural Aging and the Role of Senescence Registry

Role: collaborator

NCT03160768Completed

Feasibility of Isolating P16 Expression

Role: collaborator

NCT02263820Completed

Novel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary Angiography

Role: lead

NCT02496234Completed

The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery

Role: lead

NCT02335333Completed

Biomarkers of Aging as Predictors of Kidney Transplant Function

Role: lead

All 7 trials loaded